drugset / Trial / NCT07144475

Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery

NCT07144475

Phase 4 Completed 90 enrolled Dharmais National Cancer Center Hospital
RandomizedParallel-groupOpen-labelOther

Summary

This clinical trial aims to compare the effects of administering Lactobacillus casei Shirota probiotics with Lactobacillus acidophilus on the outcomes of patients after colorectal cancer surgery. Researchers will compare probiotic to see if Lactobacillus casei Shirota improves gastrointestinal function, sepsis incidence, C-reactive protein (CRP), interleukin 6 (IL-6), and length of stay better than Lactobacillus acidophilus. Participants will take probiotics three times daily for three days before surgery.

Timeline

Start
2024-01-01
Primary completion
2024-11-30
Completion
2025-03-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactobacillus acidophilus Other / unclassified 1e+09 unknown
Comparator Lactobacillus casei Shirota Other / unclassified 6.5e+09 unknown

Indications